HQLNYQFinancial Services

Abrdn Life Sciences Investors

+1.6% · 90d

$17.56

+0.29 (+1.68%)

After-Hours $17.57(+0.01)

News

No News Yet

Press releases and SEC filings for HQL will appear here as they are published.

Check back later for updates

Key Data

Market Cap$534.0M

Open$17.37

Prev Close$17.27

Day Range$17.44 – $17.68

52W Range$11.88 – $18.10

Volume81,184

P/E (TTM)6.29

EPS$2.79

Dividend Yield12.97%

Beta0.74

Profit Margin4415.74%

Revenue Growth-69.90%

About

Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as market position for services or products, experience of business management, technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotech Index and the S&P 500 Index. Abrdn Life Sciences Investors was formed on February 20, 1992 and is domiciled in the United States.

Financial Services · Asset Management

Top Institutional Holders

As of 2025-12-31 · prior 2025-09-30

MORGAN STANLEY$19.5M

1,164,826 sh+33.8%

Royal Bank of Canada$1.7M

104,088 sh-80.2%

Saba Capital Management, L.P.$35.5M

2,117,174 sh-18.1%

RAYMOND JAMES FINANCIAL INC$10.0M

597,055 sh+41.1%

LPL Financial LLC$7.5M

448,846 sh+20.0%

See all holders →